Discovery of a novel, liver-targeted thyroid hormone receptor-β agonist, CS271011, in the treatment of lipid metabolism disorders.
Frontiers in endocrinology（2023）
摘要
CS271011 is a potent and liver-targeted THR-β agonist for treating lipid metabolism disorders.
更多查看译文
关键词
Resmetirom,dyslipidaemia,steatosis,thyroid hormone receptor,triglycerides
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要